Back

SARS-CoV-2 20I/501Y.V1 variant in the hamster model

Cochin, M.; Luciani, L.; Touret, F.; Driouich, J. S.; Petit, P.-R.; Moureau, G.; Baronti, C.; Maes, P.; Boudewijns, R.; Neyts, J.; de Lamballerie, X.; Nougairede, A.

2021-04-19 microbiology
10.1101/2021.04.19.440435 bioRxiv
Show abstract

Late 2020, SARS-CoV-2 Alpha variant from lineage B.1.1.7 emerged in United Kingdom and gradually replaced the G614 strains initially involved in the global spread of the pandemic. In this study, we used a Syrian hamster model to compare a clinical strain of Alpha variant with an ancestral G614 strain. The Alpha variant succeeded to infect animals and to induce a pathology that mimics COVID-19. However, both strains replicated to almost the same level and induced a comparable disease and immune response. A slight fitness advantage was noted for the G614 strain during competition and transmission experiments. These data do not corroborate the epidemiological situation observed during the first half of 2021 in humans nor reports that showed a more rapid replication of Alpha variant in human reconstituted bronchial epithelium.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.